Accuray Incorporated

Accuray Incorporatedverified

ARAY

Price:

$1.93

Market Cap:

$194.09M

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated rad...[Read more]

Industry

Medical - Specialties

IPO Date

2007-02-08

Stock Exchange

NASDAQ

Ticker

ARAY

The Enterprise Value as of November 2024 (TTM) for Accuray Incorporated (ARAY) is 343.67M

According to Accuray Incorporated’s latest financial reports and current stock price. The company's current Enterprise Value is 343.67M. This represents a change of -4.41% compared to the average of 359.51M of the last 4 quarters.

Accuray Incorporated (ARAY) Historical Enterprise Value (quarterly & annually)

How has ARAY Enterprise Value performed in the past?

The mean historical Enterprise Value of Accuray Incorporated over the last ten years is 436.39M. The current 343.67M Enterprise Value has changed 7.78% with respect to the historical average. Over the past ten years (40 quarters), ARAY's Enterprise Value was at its highest in in the March 2015 quarter at 837.88M. The Enterprise Value was at its lowest in in the June 2020 quarter at 298.35M.

Quarterly (TTM)
Annual

Average

436.39M

Median

453.93M

Minimum

296.57M

Maximum

650.89M

Accuray Incorporated (ARAY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Accuray Incorporated Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 68.26%

Maximum Annual Enterprise Value = 650.89M

Minimum Annual Increase = -38.78%

Minimum Annual Enterprise Value = 296.57M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024315.14M-34.73%
2023482.84M58.05%
2022305.50M-38.78%
2021499.02M68.26%
2020296.57M-30.22%
2019425.03M7.32%
2018396.06M-18.23%
2017484.34M-4.75%
2016508.48M-21.88%
2015650.89M-15.14%

Accuray Incorporated (ARAY) Average Enterprise Value

How has ARAY Enterprise Value performed in the past?

The current Enterprise Value of Accuray Incorporated (ARAY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

367.82M

5-year avg

379.81M

10-year avg

436.39M

Accuray Incorporated (ARAY) Enterprise Value vs. Peers

How is ARAY’s Enterprise Value compared to its peers?

Accuray Incorporated’s Enterprise Value is less than Surmodics, Inc. (554.56M), less than AxoGen, Inc. (637.27M), less than Bioventus Inc. (1.11B), less than Cutera, Inc. (380.98M), less than NuVasive, Inc. (2.84B), less than Paragon 28, Inc. (910.24M), less than Orthofix Medical Inc. (829.81M), less than SI-BONE, Inc. (535.06M), less than Avanos Medical, Inc. (968.00M), greater than Aziyo Biologics, Inc. (40.84M), greater than Apyx Medical Corporation (65.23M), greater than INVO Bioscience, Inc. (7.69M), less than Artivion, Inc. (1.49B), greater than Anika Therapeutics, Inc. (213.70M), greater than Sight Sciences, Inc. (120.25M), greater than Cytosorbents Corporation (-5608216041.00), less than NeuroPace, Inc. (347.61M), greater than ClearPoint Neuro, Inc. (308.59M), greater than TELA Bio, Inc. (142.23M), less than OrthoPediatrics Corp. (611.40M),

Build a custom stock screener for Accuray Incorporated (ARAY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Accuray Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Accuray Incorporated (ARAY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Accuray Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Accuray Incorporated's Enterprise Value?

What is the highest Enterprise Value for Accuray Incorporated (ARAY)?

What is the 3-year average Enterprise Value for Accuray Incorporated (ARAY)?

What is the 5-year average Enterprise Value for Accuray Incorporated (ARAY)?

How does the current Enterprise Value for Accuray Incorporated (ARAY) compare to its historical average?